Evogene (EVGN) Institutional Ownership $1.31 -0.04 (-2.96%) Closing price 04:00 PM EasternExtended Trading$1.34 +0.03 (+2.67%) As of 05:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Evogene (NASDAQ:EVGN)CurrentInstitutional OwnershipPercentage10.40%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$138.42KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$270.75K Get EVGN Insider Trade Alerts Want to know when executives and insiders are buying or selling Evogene stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data EVGN Institutional Buying and Selling by Quarter Evogene Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/19/2025Jane Street Group LLC33,732$42K0.0%+58.0%0.629% 5/15/2025Armistice Capital LLC316,024$395K0.0%+5.9%5.890% 2/17/2025Citadel Advisors LLC15,891$30K0.0%N/A0.296% 2/14/2025Jane Street Group LLC21,345$40K0.0%N/A0.397% 11/13/2024BNP Paribas Financial Markets12,200$37K0.0%-87.8%0.227% 10/10/2024 Renaissance Investment Group LLC10,000$31K0.0%N/A0.024% 5/1/2024BNP Paribas Financial Markets91,400$69K0.0%+30.8%0.222% 11/13/2023Silverarc Capital Management LLC3,100,000$1.82M0.6%+3,000.0%7.521% 8/15/2023Silverarc Capital Management LLC100,000$107K0.0%N/A0.243% 7/27/2023Virtu Financial LLC27,333$29K0.0%N/A0.066% Get the Latest News and Ratings for EVGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Evogene and its competitors with MarketBeat's FREE daily newsletter. 10/28/2022Silverarc Capital Management LLC167,510$139K0.0%-17.2%0.407% 7/25/2022Silverarc Capital Management LLC202,322$156K0.0%-31.6%0.786% 4/20/2022Sigma Planning Corp31,410$41K0.0%+88.0%0.122% 2/1/2022Eidelman Virant Capital113,000$185K0.1%N/A0.439% 1/28/2022ARK Investment Management LLC3,611,842$6.02M0.0%-10.4%14.027% 11/16/2021Squarepoint Ops LLC45,299$120K0.0%-53.6%0.176% 11/16/2021Susquehanna International Group Ltd.42,546$113K0.0%+51.2%0.165% 11/12/2021Renaissance Technologies LLC265,200$700K0.0%+176.8%1.030% 11/12/2021Senvest Management LLC230,606$609K0.0%-49.4%0.896% 11/12/2021Jump Financial LLC16,800$44K0.0%-71.4%0.065% 11/12/2021Vident Investment Advisory LLC47,160$125K0.0%N/A0.183% 11/3/2021Crestwood Advisors Group LLC14,000$37K0.0%N/A0.054% 10/28/2021Sigma Planning Corp20,110$53K0.0%-19.9%0.078% 10/20/2021Csenge Advisory Group34,700$91K0.0%+20.9%0.135% 8/16/2021Squarepoint Ops LLC97,592$334K0.0%-14.6%0.379% 8/16/2021PDT Partners LLC166,217$568K0.0%-10.4%0.646% 8/16/2021Cubist Systematic Strategies LLC16,633$57K0.0%-41.8%0.065% 8/16/2021Occudo Quantitative Strategies LP27,481$94K0.0%N/A0.107% 8/16/2021Morgan Stanley901,584$3.08M0.0%+15.8%3.501% 8/16/2021Goldman Sachs Group Inc.36,873$126K0.0%-21.0%0.143% 8/13/2021Renaissance Technologies LLC95,800$328K0.0%N/A0.372% 8/13/2021Senvest Management LLC455,340$1.56M0.0%-38.6%1.768% 8/13/2021Jump Financial LLC58,700$201K0.0%+6.5%0.228% 8/13/2021LPL Financial LLC59,485$203K0.0%+21.7%0.231% 8/13/2021Geode Capital Management LLC26,731$91K0.0%+40.9%0.104% 8/12/2021XTX Topco Ltd21,169$72K0.0%N/A0.082% 8/12/2021Dimensional Fund Advisors LP39,044$134K0.0%+75.4%0.152% 8/12/2021JPMorgan Chase & Co.192,887$660K0.0%-3.6%0.749% 8/11/2021Susquehanna International Group Ltd.28,143$96K0.0%N/A0.109% 8/5/2021ARK Investment Management LLC4,193,343$14.36M0.0%-12.6%16.285% 5 Stocks Poised to Soar Under Trump's Presidency (Ad)With the next presidential cycle heating up and Trump leading the charge, major market shifts are already taking shape. For investors who position early, the opportunities could be significant. That’s why we’ve just released a brand-new report: 📈 “5 Best Stocks to Buy Under Trump’s Presidency.”Get the full report here—and stay ahead of the curve.8/2/2021SNS Financial Group LLC10,000$34K0.0%N/A0.039% 7/31/2021We Are One Seven LLC26,880$92K0.0%-17.5%0.104% 5/19/2021Squarepoint Ops LLC114,225$576K0.0%+46.9%0.444% 5/18/2021Millennium Management LLC292,015$1.47M0.0%N/A1.134% 5/18/2021Morgan Stanley778,430$3.92M0.0%+201.2%3.023% 5/18/2021Cubist Systematic Strategies LLC28,584$144K0.0%N/A0.111% 5/17/2021Royal Bank of Canada81,513$411K0.0%+22.6%0.317% 5/17/2021HRT Financial LP15,043$75K0.0%N/A0.058% 5/17/2021Goldman Sachs Group Inc.46,654$235K0.0%N/A0.181% 5/14/2021Dimensional Fund Advisors LP22,263$112K0.0%+65.0%0.086% 5/13/2021Citigroup Inc.7,350$34K0.0%N/A0.029% (Data available from 1/1/2016 forward) EVGN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of EVGN shares? During the previous two years, the following institutional investors and hedge funds held shares of Evogene shares: Silverarc Capital Management LLC ($1.82M), Armistice Capital LLC ($395K), Jane Street Group LLC ($42K), BNP Paribas Financial Markets ($37K), Renaissance Investment Group LLC ($31K), and Citadel Advisors LLC ($30K), and Virtu Financial LLC ($29K).Learn more on Evogene's institutional investors. What percentage of Evogene's stock is owned by institutional investors? 10.40% of Evogene's stock is owned by institutional investors. Learn more on EVGN's institutional investor holdings. Which institutional investors have been buying Evogene's stock? The following institutional investors have purchased Evogene's stock in the last 24 months: Silverarc Capital Management LLC ($3.10M), Jane Street Group LLC ($33.73K), Virtu Financial LLC ($27.33K), BNP Paribas Financial Markets ($21.50K), Armistice Capital LLC ($17.74K), Citadel Advisors LLC ($15.89K), and Renaissance Investment Group LLC ($10K). How much institutional buying is happening at Evogene? Institutional investors have bought a total of 77,366 shares in the last 24 months. This purchase volume represents approximately $138.42K in transactions. Which of Evogene's major shareholders have been selling company stock? The following institutional investors have sold Evogene stock in the last 24 months: BNP Paribas Financial Markets ($88.19K). How much institutional selling is happening at Evogene? Institutional investors have sold a total of 88,191 shares in the last 24 months. This volume of shares sold represents approximately $270.75K in transactions. Related Companies CARM Institutional Ownership SDST Institutional Ownership TOMZ Institutional Ownership BSLK Institutional Ownership DNMR Institutional Ownership TANH Institutional Ownership ICL Institutional Ownership PCTTU Institutional Ownership LIN Institutional Ownership NTR Institutional Ownership This page (NASDAQ:EVGN) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evogene Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Evogene With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
